Outcome of Patients Treated With RRT
1 other identifier
observational
2,000
1 country
1
Brief Summary
Acute Kidney Injury (AKI) is a common serious complication after cardiac surgery. AKI not only prolongs the hospitalization time of patients undergoing cardiac surgery and increases the cost of treatment, but also is an independent risk factor for postoperative death. The aim of this study is to investigate the outcome of patients treated with renal replacement therapy (RRT), and to evaluate the short-term and long-term outcomes of patients with RRT.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedFirst Submitted
Initial submission to the registry
May 26, 2020
CompletedFirst Posted
Study publicly available on registry
May 28, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedApril 18, 2022
April 1, 2022
14 years
May 26, 2020
April 15, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
All-cause mortality
30 days after Renal replacement therapy
Secondary Outcomes (1)
ICU Length of Stay (LOS)
from ICU admission to ICU discharge, within 30 days of admission
Interventions
Renal replacement therapy (RRT) refers to modalities of treatment that are used to replace the waste filtering functions of a normal kidney.
Eligibility Criteria
Patients receiving RRT for renal support
You may qualify if:
- Critically ill patients undergoing cardiovascular surgery admitted to intensive care units.
- Patients receiving RRT for renal support
- Patients over 18 years of age
You may not qualify if:
- Patients \<18 years
- Refusal of consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The first affiliated hospital of nanjing medical university
Nanjing, Jiangsu, 210029, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Yong-feng Shao, MD
First Hospital Affiliated to Nanjing Medical University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- : Investigator of Department of Cardiac Surgery
Study Record Dates
First Submitted
May 26, 2020
First Posted
May 28, 2020
Study Start
January 1, 2012
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
April 18, 2022
Record last verified: 2022-04